Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2013 Sep 30;13:453.
doi: 10.1186/1471-2334-13-453.

Comparison of the New Mycofast Revolution Assay With a Molecular Assay for the Detection of Genital Mycoplasmas From Clinical Specimens

Affiliations
Free PMC article
Comparative Study

Comparison of the New Mycofast Revolution Assay With a Molecular Assay for the Detection of Genital Mycoplasmas From Clinical Specimens

Mathys J Redelinghuys et al. BMC Infect Dis. .
Free PMC article

Abstract

Background: Genital mycoplasmas are opportunistic bacteria that are associated with undesirable gynaecologic and reproductive events. Mycoplasmas are fastidious bacteria with increasing resistance to routine antimicrobials and often fail to grow on conventional culture methods. The commercial Mycofast Revolution assay permits the phenotypic detection and identification of genital mycoplasmas. Antimicrobial susceptibility testing against five antimicrobial agents with MICs corresponding to the CLSI guidelines can also be performed. This study aimed to compare the new commercially available Mycofast Revolution assay with a multiplex PCR assay.

Methods: Self-collected swabs were obtained from pregnant women attending the antenatal clinic of a tertiary academic hospital in Pretoria, South Africa from October 2012 to November 2012. These swabs were used to seed UMMt and modified Amies transport media. The seeded UMMt transported medium was used to inoculate the Mycofast Revolution assay for the identification, enumeration and antimicrobial susceptibility testing of genital mycoplasmas. Following DNA extraction from the modified Amies transport medium, specimens were subjected to a multiplex PCR assay for the detection of genital mycoplasmas.

Results: The Mycofast Revolution kit had a sensitivity and specificity of 77.3% (95% CI: 62.15% to 88.51%) and 80% (95% CI: 28.81% to 96.70%), respectively, against the PCR assay. The positive and negative predictive values were 97.1% (95% CI: 85.03% to 99.52%) and 28.6% (95% CI: 8.57% to 58.08%). Genital mycoplasmas were detected in 71.4% (35/49) of samples with the Mycofast Revolution assay with 49% (24/49) being Ureaplasma spp. and 22.4% (11/49) mixed strains. The multiplex PCR assay had a positivity rate of 89.8% (44/49) for genital mycoplasmas; mixed strains were present in 51% (25/49) of samples, Ureaplasma spp. in 16.3% (8/49) and M. hominis in 22.4% (11/49) of samples.

Conclusions: There was a fair agreement (κ = 0.319) between the Mycofast Revolution assay and the mPCR assay. With the high prevalence rates of genital mycoplasmas, fast and efficient diagnostic methods are imperative to treat infections and minimise complications. The Mycofast Revolution assay is simple to use, has a short turn-around time and interpretation of results are straightforward. This assay circumvents common problems experienced with conventional culture and molecular methods in diagnostic laboratories where skilled personnel are limited and can be used as an alternative diagnostic assay.

Similar articles

See all similar articles

Cited by 5 articles

References

    1. Koh E, Kim S, Kim I, Maeng K, Lee S. Antimicrobial susceptibilities of Ureaplasma urealyticum and Mycoplasma hominis in pregnant women. Korean J Clin Microbiol. 2009;12:159–162. doi: 10.5145/KJCM.2009.12.4.159. - DOI
    1. Xiao L, Glass JI, Paralanov V, Yooseph S, Cassell GH, Duffy LB, Waites KB. Detection and characterization of human Ureaplasma species and serovars by real-time PCR. J Clin Microbiol. 2010;48:2715–2723. doi: 10.1128/JCM.01877-09. - DOI - PMC - PubMed
    1. Govender S, Theron GB, Odendaal HJ, Chalkley LJ. Prevalence of genital mycoplasmas, ureaplasmas and chlamydia in pregnancy. J Obstet Gynaecol. 2009;29:698–701. doi: 10.3109/01443610903184033. - DOI - PubMed
    1. Waites KB, Katz B, Schelonka RL. Mycoplasmas and ureaplasmas as neonatal pathogens. Clin Microbiol Rev. 2005;18:757–89. doi: 10.1128/CMR.18.4.757-789.2005. - DOI - PMC - PubMed
    1. Patel MA, Nyirjesy P. Role of Mycoplasma and Ureaplasma Species in Female Lower Genital Tract Infections. Curr Infect Dis Rep. 2010;12:417–422. doi: 10.1007/s11908-010-0136-x. - DOI - PubMed

Publication types

LinkOut - more resources

Feedback